Autoimmune and CTD Flashcards

1
Q

Name two genetic CTD

A
  1. Marfans Syndrome - autosomal dominant, faulty collagen that leads to many skeletal changes, Signs = tall, long fingers and toes, chest deformities
  2. Ehlers Danlos Syndrome = skin hyperelastiicty
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name 5 Autoimmune CTD

A
  1. SLE
  2. Systemic Sclerosis
  3. Sjögren’s Syndrome (SjS)
  4. Dermatomyositis/ Polymyositis
  5. Mixed CTD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe pathophysiology of Autoimmune CTD

A
  1. Inflammation leading organs scarring +/- failure
  2. Early systemic involvement may not give rise to any Sx
  3. Any systems can be affected: commonly skin, joints, kidney, lungs, blood cells and nervous systems
  4. Although there is no cure and damage is irreversible, inflammation can be treated with immunosuppressive drugs.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Raynaud’s Phenomenon?

A
  1. Peripheral digital ischaemia.
  2. Finger or toes change colour from PALE (ischaemia, lack of blood flow) –> BLUE (lack of oxygen) –> RED (blood flow returns)
  3. It can lead to tissue necrosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Primary and Secondary causes of Raynaud’s Phenomenon

A
  1. Primary (aka Raynaud’s disease)
    - Idiopathic
    - Younger age, no underlying disease
  2. Secondary
    - CTD (SLE, Scleroderma, derma-polymyositis, RA, primary SjS)
    - Drugs = Beta-blockers (slows HR, lower BP)
    - Vascular damage: atherosclerosis, frost bite, DIY vibrating tools
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Management of Raynaud’s Phenomenon

A
  • Smoking cessation
  • Avoid exposure to cold
  • Change occupation/DIY habit
  • Topical glyceryl trinitrate (vasodilator)
  • CCB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Mixed CTD and how may they present?

A

Combined features of systemic sclerosis, SLE, polymyositis

Presentation

  • Raynaud’s Phenomenon
  • arthralgias, swollen joints
  • Dysphagia: oesophageal dysfunction
  • muscle weakness
  • dactylitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathophysiology of SLE

A
  1. SLE is an antigen driven immune mediated disease characterised by activation of autoreactive T and B-cells resulting in production of pathogenic autoantibodies and tissue insult.
  2. Antigen-antibody complexes are formed and circulate the body until it is able to deposit or stick onto vessels or organs.
  3. Deposited complexes then initiate inflammatory and complement systems which causes cell damage and death (type 3 hypersensitivity).
  4. Some SLE individuals develop antibodies against RBC, WBC, platelets causing pancytopenia. This is a Type 2 hypersensitivity reaction.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are SLE Sx non-specific

A

Presentation can vary greatly between patients.

  • Sx can present suddenly or gradually over time.
  • Sx can be general = Joint pain, Rash, Fever, Weight loss
  • Sx can be specific depending on organ/tissue damaged
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diagnosis criteria of SLE

A

Dx: must meet 4 of the 11 key Sx and lab findings

SOAP BRAIN MD

S = Serositis, Pleuritis, Pericarditis, Peritonitis 
O = oral ulcers
A = arthritis
P = Photosensitivity 
B = blood: anaemia, thrombocytopenia, leukopenia
R = Renal damage
A = +ANA 
I = Immunological: anti-dsDNA, anti-smith, anti-phospholipid
N = Neurological: seizures, peripheral neuropathy 
M = alar rash 
D = discoid rash
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Investigation of SLE

A

Serology

  • ANA
  • Anti-dsDNA, Anti-smith, Anti-phospholipids
  • Complements: Dec in C3, C4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management of SLE - conservative, maintenance, flare-ups

A

Conservative
(1.) UV protection: Avoid sunlight, cover up, high factor sunblock

Maintenance

(1. ) NSAIDs for joint and muscle pains, headaches
(2. ) Immunosuppressants depending on severity and systems affected, consider:
- Corticosteroids
- Hydroxychloroquine
- Azathioprine
- methotrexate
- Belimumab (add on therapy for autoantibody +ve disease where high activity)

Flare-up Mx

  1. Hydroxychloroquine or low dose steroids for MILD flares (topical for skin)
  2. DMARDs or mycophenolate for MODERATE flares (organ involvement)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Sjorgen’s syndrome? RF? Aetiology? Triggers?

A

(1. ) AI: immune cells attack exocrine/secretary glands including: saliva, tears, vaginal.
(2. ) As a result, glands do not function leading to dry eyes, mouth, GI tract - leading to irritation of eyes, difficulty swallowing, difficulties having sex.
(3. ) Usually develop as a complication of other autoimmune diseases such as lupus or RA

RF = female of child bearing age, Africa/Asian ethnicity in Europe, Fx of SLE, smoking, sun exposure

Aetiology

  • unknown
  • genetic (HLA genes) and environmental factors (exocrine gland infection) have a role

Triggers = UV light, Oestrogen, Medication - isoniazid, hydralazine, procainamide, quinidine, etc (Drug-induced Lupus), Smoking, Bacteria, viral infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pathophysiology of Sjs

A

(1. ) In Sjogren’s, ANAs are raised these are anti-SSA & anti-SSB.
(2. ) Antibodies and T-cells enter circulation and reach glands, where cytokines release and inflammation occurs.
(3. ) Cytokines activate fibroblasts in tissue, which produce fibrous tissue that replaces damaged tissue.
(4. ) The end result is a loss secretory cells in the glands.

(5. ) Primary Sjs, occurs alone = sicca syndrome.
- Secondary Sjs occurs with other AI conditions such as RA, SLE, Scleroderma, Primary biliary cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sx of SjS

A

Dryness of various systems, the following may be present;

(1. ) Keratoconjunctivitis: redness and itching of eye
(2. ) Xerostomia: complain of swallowing difficulty
(3. ) Ulceration, perforation of nasal septum
(4. ) Difficulty speaking
(5. ) Enlargement glands e.g. parotid can cause pinching of nerves
(6. ) Infection is more common due to dryness of epithelium
(7. ) Dryness of skin and vagina

Other Clinical features

  • Arthritis
  • Rash
  • Neurological features
  • Vasculitis
  • Inc risk of lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ix of Sjs (5).

A

(1. ) Bloods
- FBC, WBC, U&E
- +ve RF in 38%
- +ve ANA in 75%
- +ve Anti-SSA/RO, anti-SS-B/LA*
- -ve dsDNA
- Raised immunoglobulin

(2. ) Schirmer’s test
- Measure conjunctival dryness

(3. ) Sialometry
- measure saliva flow.

(4. ) Biopsy
- shows lymphocytic infiltrate and thickening of the inner duct wall.
- Sialadenitis

(5. ) US
- Abnormal salivary glands

17
Q

Tx of Sjs

A

(1. ) Tears and Saliva replacement
- Hypromellose (eyedrops)
- Frequent drinks, sugar free pastilles/gums

(2. ) For organ-threatening extra glandular disease
- Corticosteroids
- Pilocarpine: increase the exocrine secretions.
- Biological therapies

18
Q

What is Systemic Sclerosis/Scleroderma? RF? Aetiology?

A

(1. ) Rare multisystem autoimmune condition that causes damage to: internal organs, function + structure of blood vessels, fibrosis of skin
(2. ) There are two types = limited and diffuse cutaneous sclerderma. Limited type is also known as Crest Syndrome.
(2. ) RF = women, Fx, infections - chlamydia, EBV, parvovirus etc, chemicals - pesticides, hair dye, immune dysregulation
(3. ) Cause is unknown, thought to be a combination of genetic and triggers (virus, dust exposure, medication)

19
Q

Pathophysiology of SS

A

(1. ) Vessels start expressing adhesion molecules, that causes T-cell to attach.
(2. ) T-cells release cytokines which causes inflammation and fibrosis of vessels
(3. ) Vessels become stiff and causes reduced blood flow leading to ischemic tissue damage
(4. ) B-cells also play a role, although mechanism is unknown, they produce ANA = Anti-SCL70, ARA, ACA
(5. ) Can affect any organs but organs commonly affected: Skin, lung, heart, kidney, GI tract

20
Q

Clinical Features of SS (hint: remember organs that are affected)

A

(1. ) Skin fibrosis:
- Sclerodactyly
- Ulcerations
- Telangiectasis - red marks on face, palms, fingers
- Subcutaneous calcinosis

(2.) Raynaud’s Phenomenon

(3. ) GI
- Oesophageal dysfunction
- Gastro-oesophageal reflux
- Reduced GI motility: Malabsorption

(4. ) Lungs
- Pulmonary arterial HTN
- Pulmonary fibrosis

(5. ) Kidney failure
(6. ) Heart failure

21
Q

Presentation in limited and diffuse scleroderma

A

Limited Scleroderma/ Crest Syndrome

  • Raynaud phenomenon usually 1st sx seen, and internal organ damage comes much later.
  • C = Calcinosis
  • R = Raynaud phenomenon
  • E = Esophageal Dysmotility
  • S = Sclerodactyly
  • T = Telangietasia

Diffuse Scleroderma

  • Skin of face, arms, legs, trunk are effected
  • Organ damage occurs earlier
22
Q

Examination of SS

A

(1. ) Chest auscultation
- Dry crackles at lung bases

(2. ) Hand examination
- Non-pitted swelling, curling of fingers
- Reduction in ROM and power
- may be unable to grip fully and make prayer signs with hand.
- Firm hard lumps (calcinosis) may also be noted.

(3. ) Presence of Telangiectasia
(4. ) Salt and pepper skin appearance due to areas of hypopigmentation and hyperpigmentation
(5. ) Dry skin and reduced hair
(6. ) Restriction in joint ROM
(7. ) Muscle atrophy may be seen

23
Q

Ix of SS

A

(1. ) Serology
- ANA +ve (90%)
- Anti-SCL70 - strongly associated w/lung fibrosis and renal disease
- ARA - kidney involvement
- ACA

Additional tests

(2. ) FBC
- may be normal
- microcytic anaemia (in chronic GI bleed)
- Haemolytic anaemia (in scleroderma renal crisis)

(3.) BP, upper endoscopy, pulmonary function tests

24
Q

Treatment and Management of SS (4.)

A

(1. ) Conservative
- Physiotherapy
- Smoking cessation
- Nutritional advice

(2. ) Immunosuppressants - cyclophosphamide
- Slows down disease for Diffuse Scleroderma

(3. ) Relive Sx
- PPI = gastric-oesophageal reflux
- CCB = for Raynaud phenomenon
- NSAIDs = for pain
- ACEi = for HTN, prevention of renal crisis
- Emollients, topical steroids = for skin issues

(4. ) Monitor BP, renal function, annual ECHO and pulmonary function tests
- For early detection of pulmonary arterial HTN

25
Q

What is Dermatomyositis and Polymyositis? Aetiology?

A

(1. ) Autoimmune mediated disease that attacks striated muscle and skin causing rash and muscle weakness
(2. ) Cause is unknown, implication of genetic (HLA DR3,5) and environmental trigger (coxsackivirus, ovarian, lung, breast tumour)

26
Q

Sx of Dermatomyositis and Polymyositis (related to muscle, skin, others)

A

Related to muscle

  1. Muscle wasting, weakness, tenderness of proximal muscles
  2. Dysphagia

Related to skin

  1. Heliotrope rash (purple rash on upper eyelids)
  2. Malar Rash
  3. Gottron’s Signs (red, scaly itchy papules)

Other Sx

  1. Fever
  2. Arthralgia
  3. Raynaud’s phenomenon
  4. Interstitial lung fibrosis
  5. Myocardial involvement - myocaridits, arrhythmias
27
Q

Investigations of Dermatomyositis and Polymyositis

A

Combination of skin and muscle findings (if specific to muscle this will be polymyositis)

(1. ) Autoanitbodies
- ANA
- Anti-Jo-1
- Anti-Mi-2

(2. ) Elevated muscle enzymes
- aldolase or creatine kinase.

(3. ) Abnormal electromyography
- detect regions of dead muscle cells that cause abnormal electrical signals conduction.

(4. ) Muscle biopsy [diagnostic]
- inflammation and necrosis.

(5.) Screen for malignancy PET, Chest Xray, PFTs, High resolution CT lungs

28
Q

Tx of Dermatomyositis and Polymyositis (5).

A
  • Corticosteroids
  • Exercise therapy: help maintain muscle function
  • Topical Hydroxychlorquine: May be used for skin rashes
  • Sun avoidance
  • Screen for cancers